MDT is in a strong uptrend
+86
BearishSidewaysBullish
Why this reading
- Price is above its 50-day average ($91.33).
- Price is above its 200-day average ($87.18).
- The 50-day average is rising (+0.12%/day).
- 50-day average is above the 200-day (long-term structure is up).
- MACD momentum is improving and the MACD line is above zero.
- Recent swings show higher highs and higher lows.
Price chart
Lower pane: RSI (14) with 70 and 30 marked. Arrows mark candlestick patterns.
Indicators
| Indicator | Value | Reading | What it means |
|---|---|---|---|
| Moving averages | Bullish stack | Bullish | 20-day $92.26, 50-day $91.33, 200-day $87.18 |
| RSI (14) | 62.0 | Bullish | Buyers have the upper hand. |
| MACD (12,26,9) | +0.31 | Bullish | MACD is above its signal line. |
| Bollinger %B | 0.82 | Neutral | Bands are 14.7% wide. |
| Volatility (ATR 14) | $2.22 (2.3%) | Neutral | Typical daily volatility. |
| Volume vs 20d avg | 0.25× | Neutral | Light volume — the latest move has little participation. |
| 52-week range | 78% | Neutral | Low $72.38, high $103.52 |
Key levels
- $103.40Resistance, 2 touches+6.8%
- $99.16Resistance, 1 touch+2.4%
- $97.03Resistance, 4 touches+0.2%
- $96.81Last close
- $92.90Support, 11 touches-4.0%
- $89.59Support, 7 touches-7.5%
- $84.87Support, 12 touches-12.3%
Recent candlestick patterns
- DojiNeutral
Open and close nearly equal — indecision between buyers and sellers.
- Hanging ManBearish
Hammer-shaped candle after an advance — can warn that buying pressure is fading.
- DojiNeutral
Open and close nearly equal — indecision between buyers and sellers.
Latest news
- Medtronic Opens Applications for Second Cohort of Spark Scholarshipfiscal.ai
- Medtronic Announces Positive Real-World Registry Results for Sphere-9 Catheter and PulseSelect PFA Systemfiscal.ai
- Medtronic CEO Geoffrey Martha Sells $4.75 Million in Sharesfiscal.ai
- Medtronic Executive Vice President Michael Marinaro Sells $1 Million in Sharesfiscal.ai
- Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’benzinga